The probiotic paradox: live and dead cells are biological response modifiers

Nutrition Research Reviews - Tập 23 Số 1 - Trang 37-46 - 2010
Catherine E. Adams1
1ANOZENE Nutritional Sciences, Fruithoflaan 103, bus 14, 2600 Berchem, Antwerp, Belgium

Tóm tắt

Probiotics are usually defined as products which contain viable non-pathogenic micro-organisms able to confer health benefits to the host. There are specific gastrointestinal effects of probiotics such as alleviating inflammatory bowel disease, reducing acute diarrhoea in children, inhibitingSalmonellaandHelicobacter pylori, removing cholesterol, secreting enzymes and bacteriocins and immunomodulation. However, many of the effects obtained from viable cells of probiotics are also obtained from populations of dead cells. Heat-killed cells ofEnterococcus faecalisstimulate the gastrointestinal immune system in chicks. Dead bifidobacteria induce significant increases in TNF-α production. Administration of heat-killedE. faecalisto healthy dogs increases neutrophil phagocytes. The probiotic paradox is that both live and dead cells in probiotic products can generate beneficial biological responses. The action of probiotics could be a dual one. Live probiotic cells influence both the gastrointestinal microflora and the immune response whilst the components of dead cells exert an anti-inflammatory response in the gastrointestinal tract. This is quite analogous to a proposed mode of action of antimicrobial growth promoters in animal production. This has several implications for the production and application of probiotics, as it will be difficult to assess the relative proportions of live and dead cells in a probiotic culture. Variable amounts of dead cells might contribute to the variation in response often seen with live probiotic cultures. However, the use of dead probiotics as biological response modifiers has several attractive advantages; such products would be very safe and have a long shelf-life.

Từ khóa


Tài liệu tham khảo

10.1128/IAI.74.2.968-974.2006

Lindberg, 1983, Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines, Infect Immun, 41, 751, 10.1128/IAI.41.2.751-757.1983

10.1093/ps/86.4.605

10.3168/jds.S0022-0302(06)72560-7

Jiang, 1999, Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo, Infect Immun, 67, 2125, 10.1128/IAI.67.5.2125-2130.1999

10.1111/j.1365-2249.1995.tb03836.x

10.1053/j.gastro.2004.02.003

10.1016/j.vetmic.2007.07.003

10.1016/j.ijfoodmicro.2007.10.004

10.3168/jds.S0022-0302(98)75549-3

10.3945/jn.109.108613

10.1053/j.gastro.2003.11.019

10.1007/s10620-006-9175-4

10.4315/0362-028X-63.5.638

10.1111/j.1753-4887.2007.tb00272.x

Matsuguchi, 2003, Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor α-inducing activities in macrophages through Toll-like receptor 2, Clin Diagn Lab Immunol, 10, 259, 10.1128/CDLI.10.2.259-266.2003

10.1128/IAI.72.9.5308-5314.2004

10.1164/rccm.200606-821OC

10.1093/jn/134.8.1964

10.3168/jds.S0022-0302(97)76232-5

10.1093/jn/135.5.1171

10.3168/jds.S0022-0302(93)77583-9

10.1111/j.1740-0929.2006.00410.x

10.1128/AEM.72.1.516-521.2006

10.1093/ps/85.2.273

10.1016/S0192-0561(97)00109-4

10.1128/AEM.67.9.4137-4143.2001

10.3168/jds.S0022-0302(87)79974-3

10.1093/jn/135.7.1752

Dotan, 2005, Probiotics in inflammatory bowel disease: possible mechanisms of action, Curr Opin Gastroenterol, 21, 426

10.1073/pnas.0809919106

10.1016/j.vetimm.2007.07.015

10.1093/ajcn/73.2.444s

10.1016/j.ijfoodmicro.2008.04.012

10.1093/ajcn/73.6.1152S

10.1021/jf073284g

10.3168/jds.S0022-0302(05)72662-X

10.3168/jds.S0022-0302(02)74406-8

10.1128/AEM.70.1.518-526.2004

10.3382/ps.2009-00436

10.1093/ps/86.8.1662

10.1093/tropej/fmp001

10.1136/bmj.39272.581736.55

10.1136/pgmj.2003.008664

10.1016/j.ijfoodmicro.2006.10.006

Guarner, 2005, The intestinal flora in inflammatory bowel disease: normal or abnormal, Curr Opin Gastroenterol, 2, 414

10.1128/IAI.01172-06

2001, Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria

Waldman, 1972, Oral immunization of mice with killed Salmonella typhimurium vaccine, Infect Immun, 6, 58, 10.1128/IAI.6.1.58-61.1972

10.1016/j.anifeedsci.2007.04.010

10.1111/j.1365-2672.2004.02353.x

10.1186/1471-2180-7-86

10.3168/jds.S0022-0302(96)76353-1

Sellon, 1998, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice, Infect Immun, 66, 5224, 10.1128/IAI.66.11.5224-5231.1998

Pessi, 1999, Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria, Appl Environ Microbiol, 65, 4725, 10.1128/AEM.65.11.4725-4728.1999

10.1093/jn/138.8.1437

10.1034/j.1398-9995.57.s72.8.x

10.1080/09540100120075844

10.3168/jds.S0022-0302(06)72557-7

Miura, 1996, Blood clearance of (1 → 3)-β-d-glucan in MRL lpr/lpr mice, FEMS Immunol Med Microbiol, 13, 51

10.1128/IAI.71.1.428-436.2003

10.3382/ps.2007-00123

10.1053/j.gastro.2007.11.059

Adams, 2007, Nutrition-based Health: Nutricines and Nutrients, Health Maintenance and Disease Avoidance in Animals

Moreau, 1988, Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice, Infect Immun, 56, 2766, 10.1128/IAI.56.10.2766-2768.1988

10.1097/00006454-200205000-00012

10.1016/j.ijfoodmicro.2006.06.009

10.1136/gut.2005.070987

Wenneras, 1992, Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine, Infect Immun, 60, 2605, 10.1128/IAI.60.7.2605-2611.1992

10.2527/jas.2004-541

Vinderola, 2005, Role of intestinal epithelial cells in immune effects mediated by Gram-positive probiotic bacteria: involvement of Toll-like receptors, Clin Diagn Lab Immunol, 12, 1075, 10.1128/CDLI.12.9.1075-1084.2005

10.1021/jf071786o